Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 23 Sept 2026 for Scholar Rock Holding Corp. Read the official filing
Filing timeline
BuySaleDavid Hallal
Insider track record
Disclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
David Hallal: trading record in brief
Filings by David Hallal span 5 companies, the busiest being Alexion Pharmaceuticals Inc, Kalaris Therapeutics, Inc. and Scholar Rock Holding Corp. The record holds 35 filings, for trades running from 4 February 2016 to 21 September 2026.
The open-market record consists of 20 sales worth €12.2M, with no purchase. The totals do not cover 11 filings with an undisclosed amount. Outside the open market, there are 10 share grants and 3 option exercises. Since January 2026: no purchases and 2 sales on the market.
Most recently, on 23 September 2026, the filings show a transaction in Scholar Rock Holding Corp. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to David Hallal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
36,652 shares0Common StockSEC:0001104659-26-110006:0
30,615 shares@ US$49.57450.022% mcap100.0% of flowCommon StockSEC:0001104659-26-045581:0
128,004 shares0Common StockSEC:0001104659-26-013580:0
57,450 shares@ US$42.7062.0% of flowCommon StockSEC:0001104659-26-004221:0
205,000 shares0Common StockSEC:0001457477-25-000004:0
38,227 shares@ US$4.30100.0% of flowCommon StockSEC:0000950170-25-083410:0
250,000 shares0Common StockSEC:0001104659-25-041457:0
13,500 shares0Common StockSEC:0001415889-24-018627:0
58,178 shares0Class A Common StockSEC:0001415889-24-016896:0
35,000 shares0Common StockSEC:0000950170-24-070600:0
23,443 shares0Class A Common StockSEC:0001209191-23-038189:0
35,000 shares0Common StockSEC:0001209191-23-029102:0
600,000 shares@ US$8.4521.9% of flowCommon StockSEC:0000899243-22-033994:0
400,000 shares@ US$7.352312.6% of flowCommon StockSEC:0000899243-22-032297:0
3,253,796 shares@ US$4.6162.1% of flowCommon StockSEC:0000899243-22-027173:0
4,227 shares@ US$5.32950.1% of flowCommon StockSEC:0000899243-22-026519:0
9,945 shares0Class A Common StockSEC:0001209191-22-038097:0
5,968 shares@ US$4.2323.5% of flowCommon StockSEC:0001209191-22-036137:0
65,725 shares@ US$3.66841.0% of flowCommon StockSEC:0000899243-22-021183:0
4,227 shares@ US$5.870.1% of flowCommon StockSEC:0000899243-22-015395:0
40,481 shares@ US$7.55371.2% of flowCommon StockSEC:0000899243-22-010762:0
17,100 shares@ US$8.00520.5% of flowCommon StockSEC:0000899243-22-003144:0
20,000 shares@ US$4.3076.5% of flowCommon StockSEC:0001209191-21-070993:0
619 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000245:0
10 sharesCommon Stock, par value $.0001 per shareSEC:0000899866-16-000245:1
25 of 35 declarations
